|
|
|
Insider
Information: |
Berman Robert Andrew |
Relationship: |
Chief Executive Office... |
City: |
Newport Beach |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
301,789 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,518,642 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
301,789 |
|
|
Total
Value |
$2,518,642 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acacia Research Corp |
ACTG |
COO, Genl Counsel, Sec... |
2007-02-09 |
30,000 |
2005-08-16 |
0 |
Premium* |
|
Anixa Biosciences Inc |
ANIX |
President & CEO, Direc... |
2017-06-02 |
61,553 |
2013-07-01 |
0 |
Premium* |
|
Envveno Medical Ord Shs |
NVNO |
Chief Executive Office... |
2022-06-27 |
210,236 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NVNO |
Envveno Medical Ord Shs |
CEO |
|
2021-11-16 |
4 |
B |
$7.87 |
$15,740 |
D/D |
2,000 |
5,736 |
2.74 |
- |
|
NVNO |
Envveno Medical Ord Shs |
CEO |
|
2021-11-19 |
4 |
B |
$7.43 |
$14,860 |
D/D |
2,000 |
7,736 |
2.81 |
- |
|
NVNO |
Envveno Medical Ord Shs |
Chief Executive Officer |
|
2019-03-12 |
4/A |
B |
$1.36 |
$25,000 |
D/D |
18,382 |
18,382 |
2.81 |
- |
|
NVNO |
Envveno Medical Ord Shs |
Chief Executive Officer |
|
2019-03-12 |
4 |
B |
$1.15 |
$25,001 |
D/D |
21,740 |
21,740 |
2.81 |
- |
|
NVNO |
Envveno Medical Ord Shs |
Chief Executive Officer |
|
2021-05-18 |
4 |
B |
$5.47 |
$16,410 |
D/D |
3,000 |
3,736 |
2.81 |
- |
|
NVNO |
Envveno Medical Ord Shs |
Chief Executive Officer |
|
2022-06-27 |
4 |
B |
$3.80 |
$9,500 |
D/D |
2,500 |
210,236 |
2.81 |
- |
|
ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
|
2006-04-26 |
4 |
AS |
$10.75 |
$598,125 |
D/D |
(55,000) |
9 |
|
- |
|
ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
|
2006-04-26 |
4 |
OE |
$1.85 |
$101,750 |
D/D |
55,000 |
27,500 |
|
- |
|
ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
|
2006-04-27 |
4 |
OE |
$1.85 |
$50,875 |
D/D |
27,500 |
27,500 |
|
- |
|
ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
|
2006-04-27 |
4 |
AS |
$11.25 |
$309,375 |
D/D |
(27,500) |
0 |
|
- |
|
ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
|
2006-05-02 |
4 |
AS |
$11.50 |
$316,250 |
D/D |
(27,500) |
0 |
|
- |
|
ACTG |
Acacia Research Corp |
COO, Gen. Counsel, Sec. |
|
2006-05-02 |
4 |
OE |
$1.85 |
$50,875 |
D/D |
27,500 |
25,000 |
|
- |
|
ACTG |
Acacia Research Corp |
COO, Genl Counsel, Secretary |
|
2007-02-07 |
4 |
AS |
$15.00 |
$32,340 |
D/D |
(2,156) |
30,000 |
0 |
- |
|
ACTG |
Acacia Research Corp |
COO, Genl Counsel, Secretary |
|
2007-02-07 |
4 |
OE |
$3.92 |
$8,445 |
D/D |
2,156 |
32,156 |
0 |
- |
|
ACTG |
Acacia Research Corp |
COO, Genl Counsel, Secretary |
|
2007-02-08 |
4 |
AS |
$15.00 |
$51,075 |
D/D |
(3,405) |
30,000 |
0 |
- |
|
ACTG |
Acacia Research Corp |
COO, Genl Counsel, Secretary |
|
2007-02-08 |
4 |
OE |
$3.92 |
$13,338 |
D/D |
3,405 |
33,405 |
0 |
- |
|
ACTG |
Acacia Research Corp |
COO, Genl Counsel, Secretary |
|
2007-02-09 |
4 |
OE |
$3.92 |
$8,226 |
D/D |
2,100 |
32,100 |
0 |
- |
|
ACTG |
Acacia Research Corp |
COO, Genl Counsel, Secretary |
|
2007-02-09 |
4 |
AS |
$15.00 |
$31,500 |
D/D |
(2,100) |
30,000 |
0 |
- |
|
ACTG |
Acacia Research Corp |
Exec. V.P., Gen. Counsel, Sec. |
|
2005-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
ANIX |
Anixa Biosciences Inc |
President & CEO |
|
2017-06-02 |
4 |
B |
$0.85 |
$8,797 |
D/D |
10,000 |
61,553 |
2.81 |
- |
|
ANIX |
Anixa Biosciences Inc |
President and CEO |
|
2013-07-01 |
4 |
A |
$0.29 |
$1,000 |
D/D |
3,447 |
6,786 |
0 |
- |
|
ANIX |
Anixa Biosciences Inc |
President and CEO |
|
2014-01-02 |
4 |
A |
$0.19 |
$1,000 |
D/D |
5,236 |
16,902 |
0 |
- |
|
ANIX |
Anixa Biosciences Inc |
President and CEO |
|
2014-01-21 |
4 |
B |
$0.21 |
$5,243 |
D/D |
25,000 |
41,902 |
2.81 |
- |
|
ANIX |
Anixa Biosciences Inc |
President and CEO |
|
2014-01-22 |
4 |
B |
$0.22 |
$10,120 |
D/D |
45,000 |
86,902 |
2.81 |
- |
|
ANIX |
Anixa Biosciences Inc |
President and CEO |
|
2014-01-24 |
4 |
B |
$0.30 |
$2,524 |
D/D |
8,500 |
95,402 |
2.73 |
- |
|
48 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|